{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:32:04Z","timestamp":1794061924133,"version":"4.8.0"},"reference-count":51,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare aggressive T-cell lymphoma most reported in Asia. We performed a comprehensive clinical, pathological and genomic study of 71 European MEITL patients (36 males, 35 females, median age 67 years). The majority presented with gastrointestinal involvement and had emergency surgery, and 40% had stage IV disease. The tumors were morphologically classified into two groups: typical (58%) and atypical (i.e., non-monomorphic or with necrosis, angiotropism or starry-sky pattern) (42%), sharing a homogeneous immunophenotypic profile (CD3+ [98%] CD4- [94%] CD5- [97%] CD7+ [97%] CD8+ [90%] CD56+ [86%] CD103+ [80%] cytotoxic marker+ [98%]) with more frequent expression of TCRgd (50%) than TCRab (32%). MYC expression (30% of cases) partly reflecting MYC gene locus alterations, correlated with non-monomorphic cytology. Almost all cases (97%) harbored deleterious mutation(s) and\/or deletion of the SETD2 gene and 90% had defective H3K36 trimethylation. Other frequently mutated genes were STAT5B (57%), JAK3 (50%), TP53 (35%), JAK1 (12.5%), BCOR and ATM (11%). Both TP53 mutations and MYC expression correlated with atypical morphology. The median overall survival (OS) of 63 patients (43\/63 only received chemotherapy after initial surgery) was 7.8 months. Multivariate analysis found a strong negative impact on outcome of MYC expression, TP53 mutation, STAT5B mutation and poor performance status while aberrant B-cell marker expression (20% of cases) correlated with better survival. In conclusion, MEITL is an aggressive disease with resistance to conventional therapy, predominantly characterized by driver gene alterations deregulating histone methylation and JAK\/STAT signaling and encompasses genetic and morphologic variants associated with very high clinical risk.<\/jats:p>","DOI":"10.3324\/haematol.2022.281226","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T04:22:18Z","timestamp":1655353338000},"page":"181-195","source":"Crossref","is-referenced-by-count":85,"title":["Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome"],"prefix":"10.3324","volume":"108","author":[{"given":"Luis","family":"Veloza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriane","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Missiaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albane","family":"Ledoux-Pilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Bisig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Poullot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Llamas-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"De Wind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Drieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fataccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Delfau-Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustine","family":"Lhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauriane","family":"Cl\u00e9ment-Filliatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Glaisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderrazak","family":"El Yamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Laribi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vallois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"De Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"43186","unstructured":"Jaffe ES, Chott A, Ott G. Intestinal T-cell lymphoma. 2017;372-80."},{"key":"43187","doi-asserted-by":"crossref","unstructured":"Vose J, Armitage J, Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008; 26(25):4124-4130.","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"43188","doi-asserted-by":"crossref","unstructured":"Laurent C, Baron M, Amara N. Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network. J Clin Oncol. 2017; 35(18):2008-2017.","DOI":"10.1200\/JCO.2016.71.2083"},{"key":"43189","doi-asserted-by":"crossref","unstructured":"Chott A, Haedicke W, Mosberger I. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol. 1998; 153(5):1483-1490.","DOI":"10.1016\/S0002-9440(10)65736-7"},{"key":"43190","doi-asserted-by":"crossref","unstructured":"Takeshita M, Nakamura S, Kikuma K. Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan. Histopathology. 2011; 58(3):395-407.","DOI":"10.1111\/j.1365-2559.2011.03768.x"},{"key":"43191","doi-asserted-by":"crossref","unstructured":"Moffitt AB, Ondrejka SL, McKinney M. Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J Exp Med. 2017; 214(5):1371-1386.","DOI":"10.1084\/jem.20160894"},{"key":"43192","doi-asserted-by":"crossref","unstructured":"Roberti A, Dobay MP, Bisig B. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nat Commun. 2016; 7:12602.","DOI":"10.1038\/ncomms12602"},{"key":"43193","doi-asserted-by":"crossref","unstructured":"Delabie J, Holte H, Vose JM. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011; 118(1):148-155.","DOI":"10.1182\/blood-2011-02-335216"},{"key":"43194","doi-asserted-by":"crossref","unstructured":"Tse E, Gill H, Loong F. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol. 2012; 87(7):663-668.","DOI":"10.1002\/ajh.23213"},{"key":"43195","doi-asserted-by":"crossref","unstructured":"Tan SY, Chuang SS, Tang T. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8\u03b1\u03b1 phenotype. Leukemia. 2013; 27(8):1688-1696.","DOI":"10.1038\/leu.2013.41"},{"key":"43196","doi-asserted-by":"crossref","unstructured":"Tomita S, Kikuti YY, Carreras J. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan. Mod Pathol. 2015; 28(10):1286-1296.","DOI":"10.1038\/modpathol.2015.85"},{"key":"43197","doi-asserted-by":"crossref","unstructured":"Sun J, Lu Z, Yang D, Chen J. Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Mod Pathol. 2011; 24(7):983-992.","DOI":"10.1038\/modpathol.2011.45"},{"key":"43198","doi-asserted-by":"crossref","unstructured":"Ko YH, Karnan S, Kim KM. Enteropathy-associated T-cell lymphoma-a clinicopathologic and array comparative genomic hybridization study. Hum Pathol. 2010; 41(9):1231-1237.","DOI":"10.1016\/j.humpath.2009.11.020"},{"key":"43199","doi-asserted-by":"crossref","unstructured":"Akiyama T, Okino T, Konishi H. CD8+, CD56+ (natural killerlike) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients. Pathol Int. 2008; 58(10):626-634.","DOI":"10.1111\/j.1440-1827.2008.02281.x"},{"key":"43200","doi-asserted-by":"crossref","unstructured":"Kikuma K, Yamada K, Nakamura S. Detailed clinicopathological characteristics and possible lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan. Hum Pathol. 2014; 45(6):1276-1284.","DOI":"10.1016\/j.humpath.2013.10.038"},{"key":"43201","unstructured":"Tan SY, de Leval L. Monomorphic epitheliotropic intestinal T-cell lymphoma. In WHO Classification of Tumors Editorial Board. Digestive system tumours, revised 5th ed. 2019;390-2."},{"key":"43202","doi-asserted-by":"crossref","unstructured":"Chan JK, Chan AC, Cheuk W. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression. Am J Surg Pathol. 2011; 35(10):1557-1569.","DOI":"10.1097\/PAS.0b013e318222dfcd"},{"key":"43203","doi-asserted-by":"crossref","unstructured":"Chen C, Gong Y, Yang Y. Clinicopathological and molecular genomic features of monomorphic epitheliotropic intestinal T-cell lymphoma in the Chinese population: a study of 20 cases. Diagn Pathol. 2021; 16(1):114.","DOI":"10.1186\/s13000-021-01173-5"},{"key":"43204","doi-asserted-by":"crossref","unstructured":"Huang D, Lim JQ, Cheah DMZ. Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma. Blood Adv. 2020; 4(19):4769-4774.","DOI":"10.1182\/bloodadvances.2020001782"},{"key":"43205","doi-asserted-by":"crossref","unstructured":"Nairism\u00e4gi ML, Tan J, Lim JQ. JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia. 2016; 30(6):1311-1319.","DOI":"10.1038\/leu.2016.13"},{"key":"43206","doi-asserted-by":"crossref","unstructured":"K\u00fc\u00e7\u00fck C, Jiang B, Hu X. Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells. Nat Commun. 2015; 6:6025.","DOI":"10.1038\/ncomms7025"},{"key":"43207","doi-asserted-by":"crossref","unstructured":"Nicolae A, Xi L, Pham TH. Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas. Leukemia. 2016; 30(11):2245-2247.","DOI":"10.1038\/leu.2016.178"},{"key":"43208","doi-asserted-by":"crossref","unstructured":"Tomita S, Kikuti YY, Carreras J. Monomorphic epitheliotropic intestinal T-cell lymphoma in Asia frequently shows SETD2 alterations. Cancers (Basel). 2020; 12(12)","DOI":"10.3390\/cancers12123539"},{"key":"43209","doi-asserted-by":"crossref","unstructured":"Yi JH, Lee GW, Do YR. Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma. Ann Hematol. 2019; 98(11):2541-2550.","DOI":"10.1007\/s00277-019-03791-y"},{"key":"43210","doi-asserted-by":"crossref","unstructured":"de Leval L, Parrens M, Le Bras F. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets. Haematologica. 2015; 100(9):e361-364.","DOI":"10.3324\/haematol.2015.126300"},{"key":"43211","doi-asserted-by":"crossref","unstructured":"Lemonnier F, Dupuis J, Sujobert P. Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. Blood. 2018; 132(21):2305-2309.","DOI":"10.1182\/blood-2018-04-840538"},{"key":"43212","doi-asserted-by":"crossref","unstructured":"Morgan EA, Pihan GA, Said JW. Profile of CD103 expression in T-cell neoplasms: immunoreactivity is not restricted to enteropathy-associated T-cell lymphoma. Am J Surg Pathol. 2014; 38(11):1557-1570.","DOI":"10.1097\/PAS.0000000000000296"},{"key":"43213","doi-asserted-by":"crossref","unstructured":"Paige AJ. Redefining tumour suppressor genes: exceptions to the two-hit hypothesis. Cell Mol Life Sci. 2003; 60(10):2147-2163.","DOI":"10.1007\/s00018-003-3027-6"},{"key":"43214","doi-asserted-by":"crossref","unstructured":"McKinney M, Moffitt AB, Gaulard P. The genetic basis of hepatosplenic T-cell lymphoma. Cancer Discov. 2017; 7(4):369-379.","DOI":"10.1158\/2159-8290.CD-16-0330"},{"key":"43215","doi-asserted-by":"crossref","unstructured":"Lemonnier F, Couronn\u00e9 L, Parrens M. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012; 120(7):1466-1469.","DOI":"10.1182\/blood-2012-02-408542"},{"key":"43216","doi-asserted-by":"crossref","unstructured":"Couronn\u00e9 L, Bastard C, Bernard OA. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med. 2012; 366(1):95-96.","DOI":"10.1056\/NEJMc1111708"},{"key":"43217","doi-asserted-by":"crossref","unstructured":"Haddad PA, Dadi N. Clinicopathologic determinants of survival in monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL): analysis of a pooled database. Blood. 2020; 136(Suppl 1):S28.","DOI":"10.1182\/blood-2020-136471"},{"key":"43218","doi-asserted-by":"crossref","unstructured":"Young KH, Weisenburger DD. Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. Blood. 2007; 110(13):4396-4405.","DOI":"10.1182\/blood-2007-02-072082"},{"key":"43219","doi-asserted-by":"crossref","unstructured":"Chapuy B, Stewart C, Dunford AJ. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018; 24(5):679-690.","DOI":"10.1038\/s41591-018-0016-8"},{"key":"43220","doi-asserted-by":"crossref","unstructured":"Kataoka K, Iwanaga M, Yasunaga JI. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma. Blood. 2018; 131(2):215-225.","DOI":"10.1182\/blood-2017-01-761874"},{"key":"43221","doi-asserted-by":"crossref","unstructured":"Watatani Y, Sato Y, Miyoshi H. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia. 2019; 33(12):2867-2883.","DOI":"10.1038\/s41375-019-0473-1"},{"key":"43222","doi-asserted-by":"crossref","unstructured":"Pham HTT, Maurer B, Prchal-Murphy M. STAT5BN642H is a driver mutation for T cell neoplasia. J Clin Invest. 2018; 128(1):387-401.","DOI":"10.1172\/JCI94509"},{"key":"43223","doi-asserted-by":"crossref","unstructured":"Rajala HL, Eldfors S, Kuusanm\u00e4ki H. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. Blood. 2013; 121(22):4541-4550.","DOI":"10.1182\/blood-2012-12-474577"},{"key":"43224","doi-asserted-by":"crossref","unstructured":"L\u00f3pez C, Bergmann AK, Paul U. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia. Br J Haematol. 2016; 173(2):265-273.","DOI":"10.1111\/bjh.13952"},{"key":"43225","doi-asserted-by":"crossref","unstructured":"Deleeuw RJ, Zettl A, Klinker E. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology. 2007; 132(5):1902-1911.","DOI":"10.1053\/j.gastro.2007.03.036"},{"key":"43226","doi-asserted-by":"crossref","unstructured":"Deng M, Xu-Monette ZY, Pham LV. Aggressive B-cell Lymphoma with MYC\/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents. Mol Cancer Res. 2021; 19(2):249-260.","DOI":"10.1158\/1541-7786.MCR-20-0466"},{"key":"43227","doi-asserted-by":"crossref","unstructured":"Chapiro E, Lesty C, Gabillaud C. &quot;Double-hit&quot; chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain. Am J Hematol. 2018; 93(3):375-382.","DOI":"10.1002\/ajh.24990"},{"key":"43228","doi-asserted-by":"crossref","unstructured":"Bachy E, Camus V, Thieblemont C. Romidepsin plus CHOP versus CHOP in patients with previously untreated peripheral T-cell lymphoma: results of the Ro-CHOP phase III study (Conducted by LYSA). J Clin Oncol. 2022; 40(3):242-251.","DOI":"10.1200\/JCO.21.01815"},{"key":"43229","doi-asserted-by":"crossref","unstructured":"Sieniawski M, Angamuthu N, Boyd K. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood. 2010; 115(18):3664-3670.","DOI":"10.1182\/blood-2009-07-231324"},{"key":"43230","doi-asserted-by":"crossref","unstructured":"Travert M, Huang Y, de Leval L. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. Blood. 2012; 119(24):5795-5806.","DOI":"10.1182\/blood-2011-12-396150"},{"key":"43231","doi-asserted-by":"crossref","unstructured":"Voss MH, Lunning MA, Maragulia JC. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. Clin Lymphoma Myeloma Leuk. 2013; 13(1):8-14.","DOI":"10.1016\/j.clml.2012.09.002"},{"key":"43232","doi-asserted-by":"crossref","unstructured":"d'Amore F, Gaulard P, Tr\u00fcmper L. ESMO Guidelines Committee. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; 26(Suppl 5):v108-115.","DOI":"10.1093\/annonc\/mdv201"},{"key":"43233","doi-asserted-by":"crossref","unstructured":"Jantunen E, Boumendil A, Finel H. Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT. Blood. 2013; 121(13):2529-2532.","DOI":"10.1182\/blood-2012-11-466839"},{"key":"43234","doi-asserted-by":"crossref","unstructured":"Schmitz N, Truemper L, Bouabdallah K. A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL. Blood. 2021; 137(19):2646-2656.","DOI":"10.1182\/blood.2020008825"},{"key":"43235","doi-asserted-by":"crossref","unstructured":"Blakolmer K, Vesely M, Kummer JA, Jurecka W, Mannhalter C, Chott A. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK\/T-) cell lymphomas. Mod Pathol. 2000; 13(7):766-772.","DOI":"10.1038\/modpathol.3880133"},{"key":"43236","doi-asserted-by":"crossref","unstructured":"Pfister SX, Markkanen E, Jiang Y. Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation. Cancer Cell. 2015; 28(5):557-568.","DOI":"10.1016\/j.ccell.2015.09.015"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281226\/74553","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281226\/75167","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10680\/74553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:01:52Z","timestamp":1794045712000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.281226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.281226","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,16]]}}}